Mergers, product prices, and innovation : evidence from the pharmaceutical industry
Year of publication: |
2024
|
---|---|
Authors: | Bonaimé, Alice ; Wang, Ye |
Published in: |
The journal of finance : the journal of the American Finance Association. - Berkeley, Calif. : AFA, ISSN 1540-6261, ZDB-ID 2010241-0. - Vol. 79.2024, 3, p. 2195-2236
|
Subject: | Pharmaindustrie | Pharmaceutical industry | Innovation | Fusion | Merger | Preismanagement | Pricing strategy | Arzneimittel | Pharmaceuticals | Preis | Price |
-
Mergers, Product Prices, and Innovation : Evidence from the Pharmaceutical Industry
Bonaime, Alice A., (2020)
-
Economics at the FTC : drug and PBM mergers and drip pricing
Shelanski, Howard A., (2012)
-
The economics of FTC V. Lundbeck : why drug mergers may not raise prices
Werden, Gregory J., (2013)
- More ...
-
Payout policy trade-offs and the rise of 10b5-1 preset repurchase plans
Bonaimé, Alice, (2020)
-
Voluntary disclosures regarding open market repurchase programs
Bargeron, Leonce, (2024)
-
The Impact of Nonfarm Activities on Agricultural Productivity in Rural China
Wang, Ye, (2011)
- More ...